China Pharma Holdings (CPHI) Gross Margin (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Gross Margin came in at 29.03% in Q1 2026, up 4100.0% YoY from 0.69% in Q1 2025, and up 136.02% on a QoQ basis from 12.3% in Q4 2025.
China Pharma Holdings (CPHI) Gross Margin (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Gross Margin data on file, last reported at 29.03% in Q1 2026.
- Quarterly Gross Margin rose 4100.0% year-over-year to 29.03% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7.26% (up 4990.0% YoY) and the FY2025 annual result came in at 3.18%, up 4066.0% from the prior year.
- Gross Margin grew to 29.03% in Q1 2026, from 12.3% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 29.03% in Q1 2026 to a low of 109.78% in Q2 2024.
- A 5-year average of 13.56% and a median of 10.56% in 2022 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2024 — Gross Margin sank 9642 bps — and 2025, when it soared 10130 bps.
- Tracing CPHI's Gross Margin over 5 years: stood at 1.46% in 2022, then tumbled by 352 bps to 3.68% in 2023, then tumbled by 285 bps to 14.16% in 2024, then surged by 187 bps to 12.3% in 2025, then soared by 136 bps to 29.03% in 2026.
- The last three Gross Margin figures came in at 29.03% (Q1 2026), 12.3% (Q4 2025), and 7.89% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 | 8.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.03% |
| Dec 31, 2025 | 12.30% |
| Sep 30, 2025 | -7.89% |
| Jun 30, 2025 | -8.48% |
| Mar 31, 2025 | -11.97% |
| Dec 31, 2024 | -14.16% |
| Sep 30, 2024 | -47.23% |
| Jun 30, 2024 | -109.78% |
| Mar 31, 2024 | -21.17% |
| Dec 31, 2023 | -3.68% |
| Sep 30, 2023 | -12.93% |
| Jun 30, 2023 | -13.36% |
| Mar 31, 2023 | 9.08% |
| Dec 31, 2022 | 1.46% |
| Sep 30, 2022 | -7.01% |
| Jun 30, 2022 | -14.22% |
| Mar 31, 2022 | -10.56% |
| Dec 31, 2021 | 10.45% |
| Sep 30, 2021 | -14.98% |
| Jun 30, 2021 | 2.94% |